Aide Health raises £1m in pre-seed funding led by Hambro Perks to support its chronic disease management platform.
The pre-seed round was led by Hambro Perks with backing from Fuel Ventures, 1818 Ventures, and APX.
Aide Health operates a digital platform that connects patients managing long-term conditions with their clinicians for remote monitoring and care management.
Aide Health has secured £1m in pre-seed funding to expand its digital health platform. The investment was led by Hambro Perks through its EIS fund, with participation from Fuel Ventures, 1818 Ventures, and APX.
The company provides software that assists patients with chronic conditions in managing treatments alongside a clinician monitoring dashboard. The service is currently utilised within the NHS for patients with asthma and type-2 diabetes, with plans to introduce pathways for additional conditions.
The fresh capital will support the company as it develops its offering and extends access to its care management tools.
From the founder
"Like many people, I know first-hand the frustrations of trying to manage long-term conditions. Our goal is to give both patients and clinicians the tools and insights they need to have better conversations and make more informed treatment decisions together. The pilot in NHS England is our first step towards making Aide available to everyone with chronic illness."
Ian Wharton
CEO at Aide Health
Use of funds
- 01Continue product development
Investors
Categories
About the company
Aide Health
Aide Health provides a digital platform for managing long-term health conditions.